Powered by

AstraZeneca: Lynparza Recommended For Marketing Authorisation In EU

Jun 01, 2020 - Nasdaq

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) and Merck & Co., Inc.(MRK) announced Monday that the European Medicines Agency or EMA recommended Lynparza (olaparib) for marketing authorisation in the European Union. The recommendation is for the 1st-line maintenance treatment of patients with germline BRCA-mutated or gBRCAm metastatic pancreatic cancer. EMA's Committee for Medicinal Products for Human Use or CHMP based its positive opinion on results from the Phase III POLO trial, which were publishe...